Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Clinical trial NCT06518018 · UNKNOWN

Trial details

NCT number: NCT06518018
Sponsor: The First People's Hospital of Neijiang
Status: UNKNOWN
Study type: OBSERVATIONAL

Advanced Stage NSCLC Second-line Treatment Patients Without Targetable Driver Mutations

Start date: 2023-09-01
Primary completion: 2025-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.